TG Therapeutics, Inc. (TGTX)
29.16
+0.11
(+0.38%)
USD |
NASDAQ |
Feb 18, 15:50
TG Therapeutics Market Cap : 4.629B for Feb. 18, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amicus Therapeutics, Inc. | 4.497B |
| MannKind Corp. | 1.667B |
| Keros Therapeutics, Inc. | 495.07M |
| ACADIA Pharmaceuticals, Inc. | 3.915B |
| Alnylam Pharmaceuticals, Inc. | 44.05B |
Market Cap Related Metrics
| PE Ratio | 10.50 |
| PS Ratio | 8.862 |
| Price to Book Value | 7.624 |
| Price | 29.16 |
| Earnings Yield | 9.53% |
| Operating PE Ratio | 45.86 |
| Normalized PE Ratio | 10.49 |